Clearstead Trust’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.2K | Sell |
233
-25
| -10% | -$8.22K | 0.01% | 282 |
|
|
2025
Q4 | $90.4K | Buy |
258
+5
| +2% | +$1.69K | 0.01% | 265 |
|
|
2025
Q3 | $81.8K | Sell |
253
-10
| -4% | -$3.11K | 0.01% | 264 |
|
|
2025
Q2 | $102K | Buy |
263
+91
| +53% | +$36.6K | 0.02% | 238 |
|
|
2025
Q1 | $74.8K | Buy |
172
+39
| +29% | +$15.7K | 0.02% | 237 |
|
|
2024
Q4 | $49.1K | Sell |
133
-621
| -82% | -$260K | 0.01% | 263 |
|
|
2024
Q3 | $392K | Hold |
754
| – | – | 0.09% | 94 |
|
|
2024
Q2 | $409K | Hold |
754
| – | – | 0.1% | 83 |
|
|
2024
Q1 | $391K | Sell |
754
-4
| -0.5% | -$1.99K | 0.1% | 87 |
|
|
2023
Q4 | $357K | Sell |
758
-5
| -0.7% | -$2.31K | 0.1% | 115 |
|
|
2023
Q3 | $332K | Sell |
763
-29
| -4% | -$13.2K | 0.11% | 88 |
|
|
2023
Q2 | $364K | Hold |
792
| – | – | 0.12% | 88 |
|
|
2023
Q1 | $364K | Hold |
792
| – | – | 0.12% | 94 |
|
|
2022
Q4 | $406K | Hold |
792
| – | – | 0.14% | 87 |
|
|
2022
Q3 | $360K | Hold |
792
| – | – | 0.13% | 87 |
|
|
2022
Q2 | $382K | Hold |
792
| – | – | 0.29% | 54 |
|
|
2022
Q1 | $389K | Hold |
792
| – | – | 0.25% | 56 |
|
|
2021
Q4 | $367K | Hold |
792
| – | – | 0.22% | 65 |
|
|
2021
Q3 | $295K | Hold |
792
| – | – | 0.19% | 71 |
|
|
2021
Q2 | $302K | Hold |
792
| – | – | 0.2% | 74 |
|
|
2021
Q1 | $284K | Hold |
792
| – | – | 0.21% | 72 |
|
|
2020
Q4 | $254K | Hold |
792
| – | – | 0.15% | 86 |
|
|
2020
Q3 | $213K | Hold |
792
| – | – | 0.17% | 83 |
|
|
2020
Q2 | $208K | Hold |
792
| – | – | 0.18% | 84 |
|
|
2020
Q1 | $180K | Sell |
792
-50
| -6% | -$13.6K | 0.16% | 87 |
|
|
2019
Q4 | $254K | Sell |
842
-217
| -20% | -$59.7K | 0.19% | 88 |
|
|
2019
Q3 | $254K | Hold |
1,059
| – | – | 0.2% | 85 |
|
|
2019
Q2 | $299K | Sell |
1,059
-253
| -19% | -$69.1K | 0.24% | 80 |
|
|
2019
Q1 | $377K | Sell |
1,312
-48
| -4% | -$13.9K | 0.31% | 72 |
|
|
2018
Q4 | $357K | Sell |
1,360
-288
| -17% | -$79.2K | 0.33% | 67 |
|
|
2018
Q3 | $452K | Sell |
1,648
-255
| -13% | -$66.2K | 0.35% | 59 |
|
|
2018
Q2 | $453K | Sell |
1,903
-197
| -9% | -$45.6K | 0.4% | 59 |
|
|
2018
Q1 | $461K | Buy |
2,100
+115
| +6% | +$27K | 0.4% | 63 |
|
|
2017
Q4 | $447K | Sell |
1,985
-23
| -1% | -$4.9K | 0.31% | 71 |
|
|
2017
Q3 | $381K | Hold |
2,008
| – | – | 0.28% | 82 |
|
|
2017
Q2 | $378K | Sell |
2,008
-106
| -5% | -$19K | 0.3% | 72 |
|
|
2017
Q1 | $350K | Buy |
2,114
+178
| +9% | +$28.3K | 0.29% | 75 |
|
|
2016
Q4 | $278K | Buy |
+1,936
| New | +$259K | 0.25% | 81 |
|
Other funds holding ELV
VCM
VPM
Clearstead Trust's ELV Position: Q1 2026 in Review
Clearstead Trust reduced its Elevance Health (ELV) stake by 9.7% in Q1 2026, selling an estimated $8.22K and leaving 233 shares worth $68.2K. The position accounts for 0.01% of the portfolio, ranked #282.
Clearstead Trust first reported a position in ELV in Q4 2016 and has held it in 38 quarters since. The position peaked at $461K in Q1 2018. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Clearstead Trust held 233 shares of Elevance Health worth $68.2K as of Q1 2026.
- Clearstead Trust sold 25 Elevance Health shares in Q1 2026, an estimated $8.22K.
- Elevance Health made up 0.01% of Clearstead Trust's portfolio in Q1 2026, its #282 holding.
- Clearstead Trust first reported a position in Elevance Health in Q4 2016 and has held it in 38 quarters since.
- Clearstead Trust's Elevance Health position peaked at $461K in Q1 2018.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Clearstead Trust's 13F filing for Q1 2026, filed 6 May 2026.